nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA2—kidney cancer	0.439	1	CbGaD
Zoledronate—ABCC1—Dactinomycin—kidney cancer	0.0806	0.299	CbGbCtD
Zoledronate—ABCC1—Paclitaxel—kidney cancer	0.0576	0.214	CbGbCtD
Zoledronate—ABCC1—Vinblastine—kidney cancer	0.0505	0.187	CbGbCtD
Zoledronate—ABCC1—Vincristine—kidney cancer	0.0496	0.184	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—kidney cancer	0.031	0.115	CbGbCtD
Zoledronate—CA2—collecting duct of renal tubule—kidney cancer	0.00921	0.191	CbGeAlD
Zoledronate—GGPS1—nephron tubule—kidney cancer	0.0037	0.0768	CbGeAlD
Zoledronate—GGPS1—renal system—kidney cancer	0.00336	0.0698	CbGeAlD
Zoledronate—GGPS1—kidney—kidney cancer	0.00325	0.0674	CbGeAlD
Zoledronate—GGPS1—cortex of kidney—kidney cancer	0.00316	0.0657	CbGeAlD
Zoledronate—GGPS1—gonad—kidney cancer	0.00301	0.0626	CbGeAlD
Zoledronate—GGPS1—cardiac atrium—kidney cancer	0.00301	0.0625	CbGeAlD
Zoledronate—CA14—cardiac atrium—kidney cancer	0.0018	0.0373	CbGeAlD
Zoledronate—FDPS—nephron tubule—kidney cancer	0.0017	0.0354	CbGeAlD
Zoledronate—CA12—renal system—kidney cancer	0.00157	0.0325	CbGeAlD
Zoledronate—FDPS—renal system—kidney cancer	0.00155	0.0322	CbGeAlD
Zoledronate—CA12—kidney—kidney cancer	0.00151	0.0314	CbGeAlD
Zoledronate—FDPS—kidney—kidney cancer	0.0015	0.0311	CbGeAlD
Zoledronate—FDPS—cortex of kidney—kidney cancer	0.00146	0.0303	CbGeAlD
Zoledronate—FDPS—gonad—kidney cancer	0.00139	0.0288	CbGeAlD
Zoledronate—FDPS—cardiac atrium—kidney cancer	0.00139	0.0288	CbGeAlD
Zoledronate—CA2—nephron tubule—kidney cancer	0.000885	0.0184	CbGeAlD
Zoledronate—ABCC1—cortex of kidney—kidney cancer	0.000847	0.0176	CbGeAlD
Zoledronate—ABCC1—cardiac atrium—kidney cancer	0.000806	0.0167	CbGeAlD
Zoledronate—CA2—renal system—kidney cancer	0.000804	0.0167	CbGeAlD
Zoledronate—CA2—kidney—kidney cancer	0.000777	0.0161	CbGeAlD
Zoledronate—CA2—cortex of kidney—kidney cancer	0.000757	0.0157	CbGeAlD
Zoledronate—CA2—cardiac atrium—kidney cancer	0.00072	0.015	CbGeAlD
Zoledronate—Risedronate—PTGS2—kidney cancer	0.000491	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—kidney cancer	0.000437	0.471	CrCbGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00014	0.00288	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PDHB—kidney cancer	0.000139	0.00287	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ITPR2—kidney cancer	0.000135	0.00279	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PDHB—kidney cancer	0.000134	0.00277	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CCBL1—kidney cancer	0.000131	0.0027	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GLIPR1—kidney cancer	0.00013	0.00268	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPAT—kidney cancer	0.00013	0.00268	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CCBL1—kidney cancer	0.000126	0.0026	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000125	0.00257	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ACHE—kidney cancer	0.000123	0.00255	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTT1—kidney cancer	0.000123	0.00255	CbGpPWpGaD
Zoledronate—CA14—Metabolism—FH—kidney cancer	0.000121	0.00249	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APRT—kidney cancer	0.000121	0.00249	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ACY1—kidney cancer	0.000121	0.00249	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000118	0.00244	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SCARB1—kidney cancer	0.000117	0.00241	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS1—kidney cancer	0.000116	0.00239	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000114	0.00235	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PSMD7—kidney cancer	0.000113	0.00234	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPAT—kidney cancer	0.000113	0.00234	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GLIPR1—kidney cancer	0.000113	0.00234	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPC3—kidney cancer	0.000113	0.00234	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000112	0.00231	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000111	0.00229	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA2—kidney cancer	0.00011	0.00228	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GLIPR1—kidney cancer	0.000109	0.00226	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPAT—kidney cancer	0.000109	0.00226	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALAD—kidney cancer	0.000108	0.00222	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—BCHE—kidney cancer	0.000108	0.00222	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SLC5A5—kidney cancer	0.000106	0.00219	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000106	0.00219	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APRT—kidney cancer	0.000105	0.00217	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—FH—kidney cancer	0.000105	0.00217	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ST3GAL2—kidney cancer	0.000105	0.00216	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000103	0.00213	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALDH1A1—kidney cancer	0.000103	0.00212	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PDHB—kidney cancer	0.000103	0.00212	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—SLC2A1—kidney cancer	0.000103	0.00212	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APRT—kidney cancer	0.000102	0.0021	CbGpPWpGaD
Zoledronate—CA12—Metabolism—FH—kidney cancer	0.000102	0.0021	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.95e-05	0.00205	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPC3—kidney cancer	9.92e-05	0.00204	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PGK1—kidney cancer	9.84e-05	0.00203	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC5A3—kidney cancer	9.84e-05	0.00203	CbGpPWpGaD
Zoledronate—CA14—Metabolism—LDHB—kidney cancer	9.65e-05	0.00199	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA2—kidney cancer	9.65e-05	0.00199	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CCBL1—kidney cancer	9.65e-05	0.00199	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPC3—kidney cancer	9.56e-05	0.00197	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALAD—kidney cancer	9.4e-05	0.00194	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA2—kidney cancer	9.3e-05	0.00192	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ST3GAL2—kidney cancer	9.17e-05	0.00189	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.09e-05	0.00187	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALAD—kidney cancer	9.06e-05	0.00187	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALDH1A1—kidney cancer	8.97e-05	0.00185	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ST3GAL2—kidney cancer	8.85e-05	0.00182	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.68e-05	0.00179	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALDH1A1—kidney cancer	8.65e-05	0.00178	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC5A3—kidney cancer	8.6e-05	0.00177	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PGK1—kidney cancer	8.6e-05	0.00177	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTP1—kidney cancer	8.56e-05	0.00176	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LDHB—kidney cancer	8.43e-05	0.00174	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA9—kidney cancer	8.36e-05	0.00172	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPAT—kidney cancer	8.36e-05	0.00172	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GLIPR1—kidney cancer	8.36e-05	0.00172	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PGK1—kidney cancer	8.29e-05	0.00171	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC5A3—kidney cancer	8.29e-05	0.00171	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LDHB—kidney cancer	8.13e-05	0.00168	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ABCB1—kidney cancer	8.1e-05	0.00167	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTM1—kidney cancer	7.86e-05	0.00162	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APRT—kidney cancer	7.78e-05	0.0016	CbGpPWpGaD
Zoledronate—CA2—Metabolism—FH—kidney cancer	7.78e-05	0.0016	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP1A1—kidney cancer	7.45e-05	0.00154	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPC3—kidney cancer	7.31e-05	0.00151	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA9—kidney cancer	7.31e-05	0.00151	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.14e-05	0.00147	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CRABP1—kidney cancer	7.11e-05	0.00147	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA9—kidney cancer	7.05e-05	0.00145	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALAD—kidney cancer	6.93e-05	0.00143	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	6.81e-05	0.0014	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ST3GAL2—kidney cancer	6.76e-05	0.00139	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALDH1A1—kidney cancer	6.61e-05	0.00136	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ITPR2—kidney cancer	6.61e-05	0.00136	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.55e-05	0.00135	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.55e-05	0.00135	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.55e-05	0.00135	CbGpPWpGaD
Zoledronate—Discomfort—Paclitaxel—kidney cancer	6.37e-05	0.000329	CcSEcCtD
Zoledronate—Fatigue—Gemcitabine—kidney cancer	6.37e-05	0.000328	CcSEcCtD
Zoledronate—Gastrointestinal pain—Vincristine—kidney cancer	6.37e-05	0.000328	CcSEcCtD
Zoledronate—CA2—Metabolism—SLC5A3—kidney cancer	6.34e-05	0.00131	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PGK1—kidney cancer	6.34e-05	0.00131	CbGpPWpGaD
Zoledronate—Dizziness—Sorafenib—kidney cancer	6.33e-05	0.000326	CcSEcCtD
Zoledronate—Constipation—Gemcitabine—kidney cancer	6.32e-05	0.000326	CcSEcCtD
Zoledronate—Pain—Gemcitabine—kidney cancer	6.32e-05	0.000326	CcSEcCtD
Zoledronate—Nausea—Erlotinib—kidney cancer	6.32e-05	0.000326	CcSEcCtD
Zoledronate—Alopecia—Capecitabine—kidney cancer	6.31e-05	0.000326	CcSEcCtD
Zoledronate—Dry mouth—Paclitaxel—kidney cancer	6.31e-05	0.000325	CcSEcCtD
Zoledronate—Diarrhoea—Sunitinib—kidney cancer	6.3e-05	0.000325	CcSEcCtD
Zoledronate—Mental disorder—Capecitabine—kidney cancer	6.26e-05	0.000323	CcSEcCtD
Zoledronate—Asthenia—Dactinomycin—kidney cancer	6.25e-05	0.000322	CcSEcCtD
Zoledronate—Confusional state—Paclitaxel—kidney cancer	6.24e-05	0.000322	CcSEcCtD
Zoledronate—Blood creatinine increased—Doxorubicin—kidney cancer	6.23e-05	0.000322	CcSEcCtD
Zoledronate—Malnutrition—Capecitabine—kidney cancer	6.22e-05	0.000321	CcSEcCtD
Zoledronate—Erythema—Capecitabine—kidney cancer	6.22e-05	0.000321	CcSEcCtD
Zoledronate—CA2—Metabolism—LDHB—kidney cancer	6.22e-05	0.00128	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CRABP1—kidney cancer	6.22e-05	0.00128	CbGpPWpGaD
Zoledronate—Dehydration—Doxorubicin—kidney cancer	6.19e-05	0.000319	CcSEcCtD
Zoledronate—Oedema—Paclitaxel—kidney cancer	6.18e-05	0.000319	CcSEcCtD
Zoledronate—Anaphylactic shock—Paclitaxel—kidney cancer	6.18e-05	0.000319	CcSEcCtD
Zoledronate—Body temperature increased—Vincristine—kidney cancer	6.15e-05	0.000317	CcSEcCtD
Zoledronate—Abdominal pain—Vincristine—kidney cancer	6.15e-05	0.000317	CcSEcCtD
Zoledronate—Infection—Paclitaxel—kidney cancer	6.14e-05	0.000317	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.12e-05	0.00126	CbGpPWpGaD
Zoledronate—Dysgeusia—Capecitabine—kidney cancer	6.09e-05	0.000314	CcSEcCtD
Zoledronate—Dizziness—Sunitinib—kidney cancer	6.09e-05	0.000314	CcSEcCtD
Zoledronate—Feeling abnormal—Gemcitabine—kidney cancer	6.09e-05	0.000314	CcSEcCtD
Zoledronate—Shock—Paclitaxel—kidney cancer	6.08e-05	0.000314	CcSEcCtD
Zoledronate—Vomiting—Sorafenib—kidney cancer	6.08e-05	0.000314	CcSEcCtD
Zoledronate—Abdominal pain upper—Doxorubicin—kidney cancer	6.08e-05	0.000314	CcSEcCtD
Zoledronate—Nervous system disorder—Paclitaxel—kidney cancer	6.06e-05	0.000313	CcSEcCtD
Zoledronate—Hypokalaemia—Doxorubicin—kidney cancer	6.06e-05	0.000312	CcSEcCtD
Zoledronate—Thrombocytopenia—Paclitaxel—kidney cancer	6.05e-05	0.000312	CcSEcCtD
Zoledronate—Tachycardia—Paclitaxel—kidney cancer	6.04e-05	0.000311	CcSEcCtD
Zoledronate—Rash—Sorafenib—kidney cancer	6.03e-05	0.000311	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTT1—kidney cancer	6.03e-05	0.00124	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ACHE—kidney cancer	6.03e-05	0.00124	CbGpPWpGaD
Zoledronate—Dermatitis—Sorafenib—kidney cancer	6.03e-05	0.000311	CcSEcCtD
Zoledronate—Back pain—Capecitabine—kidney cancer	6.01e-05	0.00031	CcSEcCtD
Zoledronate—Skin disorder—Paclitaxel—kidney cancer	6.01e-05	0.00031	CcSEcCtD
Zoledronate—CA12—Metabolism—CRABP1—kidney cancer	5.99e-05	0.00124	CbGpPWpGaD
Zoledronate—Headache—Sorafenib—kidney cancer	5.99e-05	0.000309	CcSEcCtD
Zoledronate—Muscle spasms—Capecitabine—kidney cancer	5.98e-05	0.000308	CcSEcCtD
Zoledronate—Hyperhidrosis—Paclitaxel—kidney cancer	5.98e-05	0.000308	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—kidney cancer	5.96e-05	0.000308	CcSEcCtD
Zoledronate—Nasopharyngitis—Doxorubicin—kidney cancer	5.95e-05	0.000307	CcSEcCtD
Zoledronate—Anorexia—Paclitaxel—kidney cancer	5.89e-05	0.000304	CcSEcCtD
Zoledronate—Gastritis—Doxorubicin—kidney cancer	5.89e-05	0.000304	CcSEcCtD
Zoledronate—Muscular weakness—Doxorubicin—kidney cancer	5.87e-05	0.000303	CcSEcCtD
Zoledronate—Vision blurred—Capecitabine—kidney cancer	5.86e-05	0.000302	CcSEcCtD
Zoledronate—Vomiting—Sunitinib—kidney cancer	5.85e-05	0.000302	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ACY1—kidney cancer	5.84e-05	0.0012	CbGpPWpGaD
Zoledronate—Body temperature increased—Gemcitabine—kidney cancer	5.84e-05	0.000301	CcSEcCtD
Zoledronate—Tremor—Capecitabine—kidney cancer	5.83e-05	0.0003	CcSEcCtD
Zoledronate—Rash—Sunitinib—kidney cancer	5.8e-05	0.000299	CcSEcCtD
Zoledronate—Dermatitis—Sunitinib—kidney cancer	5.8e-05	0.000299	CcSEcCtD
Zoledronate—Abdominal distension—Doxorubicin—kidney cancer	5.79e-05	0.000299	CcSEcCtD
Zoledronate—FDPS—Metabolism—ITPR2—kidney cancer	5.78e-05	0.00119	CbGpPWpGaD
Zoledronate—Hypotension—Paclitaxel—kidney cancer	5.78e-05	0.000298	CcSEcCtD
Zoledronate—Ill-defined disorder—Capecitabine—kidney cancer	5.77e-05	0.000298	CcSEcCtD
Zoledronate—Headache—Sunitinib—kidney cancer	5.77e-05	0.000297	CcSEcCtD
Zoledronate—Influenza—Doxorubicin—kidney cancer	5.75e-05	0.000297	CcSEcCtD
Zoledronate—Asthma—Doxorubicin—kidney cancer	5.75e-05	0.000297	CcSEcCtD
Zoledronate—Dysphagia—Doxorubicin—kidney cancer	5.75e-05	0.000297	CcSEcCtD
Zoledronate—Anaemia—Capecitabine—kidney cancer	5.75e-05	0.000296	CcSEcCtD
Zoledronate—Hypersensitivity—Vincristine—kidney cancer	5.74e-05	0.000296	CcSEcCtD
Zoledronate—CA14—Metabolism—SCARB1—kidney cancer	5.71e-05	0.00118	CbGpPWpGaD
Zoledronate—Nausea—Sorafenib—kidney cancer	5.68e-05	0.000293	CcSEcCtD
Zoledronate—CA14—Metabolism—PTGS1—kidney cancer	5.65e-05	0.00116	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.63e-05	0.000291	CcSEcCtD
Zoledronate—Malaise—Capecitabine—kidney cancer	5.61e-05	0.000289	CcSEcCtD
Zoledronate—Insomnia—Paclitaxel—kidney cancer	5.59e-05	0.000288	CcSEcCtD
Zoledronate—Vertigo—Capecitabine—kidney cancer	5.59e-05	0.000288	CcSEcCtD
Zoledronate—Asthenia—Vincristine—kidney cancer	5.59e-05	0.000288	CcSEcCtD
Zoledronate—Syncope—Capecitabine—kidney cancer	5.58e-05	0.000288	CcSEcCtD
Zoledronate—ABCC1—Disease—CCBL1—kidney cancer	5.58e-05	0.00115	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ITPR2—kidney cancer	5.57e-05	0.00115	CbGpPWpGaD
Zoledronate—Leukopenia—Capecitabine—kidney cancer	5.57e-05	0.000287	CcSEcCtD
Zoledronate—GGPS1—Metabolism—POMC—kidney cancer	5.56e-05	0.00115	CbGpPWpGaD
Zoledronate—Paraesthesia—Paclitaxel—kidney cancer	5.55e-05	0.000286	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—kidney cancer	5.54e-05	0.000286	CcSEcCtD
Zoledronate—CA14—Metabolism—PSMD7—kidney cancer	5.54e-05	0.00114	CbGpPWpGaD
Zoledronate—Dyspnoea—Paclitaxel—kidney cancer	5.51e-05	0.000284	CcSEcCtD
Zoledronate—Somnolence—Paclitaxel—kidney cancer	5.5e-05	0.000284	CcSEcCtD
Zoledronate—Palpitations—Capecitabine—kidney cancer	5.49e-05	0.000283	CcSEcCtD
Zoledronate—Rash—Dactinomycin—kidney cancer	5.49e-05	0.000283	CcSEcCtD
Zoledronate—Nausea—Sunitinib—kidney cancer	5.47e-05	0.000282	CcSEcCtD
Zoledronate—Loss of consciousness—Capecitabine—kidney cancer	5.46e-05	0.000282	CcSEcCtD
Zoledronate—Pancytopenia—Doxorubicin—kidney cancer	5.46e-05	0.000282	CcSEcCtD
Zoledronate—Dyspepsia—Paclitaxel—kidney cancer	5.44e-05	0.000281	CcSEcCtD
Zoledronate—Cough—Capecitabine—kidney cancer	5.43e-05	0.00028	CcSEcCtD
Zoledronate—CA2—Metabolism—CA9—kidney cancer	5.39e-05	0.00111	CbGpPWpGaD
Zoledronate—Neutropenia—Doxorubicin—kidney cancer	5.38e-05	0.000277	CcSEcCtD
Zoledronate—Decreased appetite—Paclitaxel—kidney cancer	5.38e-05	0.000277	CcSEcCtD
Zoledronate—Hypertension—Capecitabine—kidney cancer	5.37e-05	0.000277	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.35e-05	0.000276	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.34e-05	0.000275	CcSEcCtD
Zoledronate—Fatigue—Paclitaxel—kidney cancer	5.33e-05	0.000275	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.33e-05	0.0011	CbGpPWpGaD
Zoledronate—Diarrhoea—Vincristine—kidney cancer	5.33e-05	0.000275	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—kidney cancer	5.31e-05	0.000274	CcSEcCtD
Zoledronate—Asthenia—Gemcitabine—kidney cancer	5.3e-05	0.000273	CcSEcCtD
Zoledronate—Chest pain—Capecitabine—kidney cancer	5.29e-05	0.000273	CcSEcCtD
Zoledronate—Myalgia—Capecitabine—kidney cancer	5.29e-05	0.000273	CcSEcCtD
Zoledronate—Arthralgia—Capecitabine—kidney cancer	5.29e-05	0.000273	CcSEcCtD
Zoledronate—Constipation—Paclitaxel—kidney cancer	5.29e-05	0.000273	CcSEcCtD
Zoledronate—Pain—Paclitaxel—kidney cancer	5.29e-05	0.000273	CcSEcCtD
Zoledronate—Anxiety—Capecitabine—kidney cancer	5.28e-05	0.000272	CcSEcCtD
Zoledronate—FDPS—Metabolism—ACHE—kidney cancer	5.27e-05	0.00109	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTT1—kidney cancer	5.27e-05	0.00109	CbGpPWpGaD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.26e-05	0.000271	CcSEcCtD
Zoledronate—CA14—Metabolism—BCHE—kidney cancer	5.25e-05	0.00108	CbGpPWpGaD
Zoledronate—Weight increased—Doxorubicin—kidney cancer	5.23e-05	0.00027	CcSEcCtD
Zoledronate—Discomfort—Capecitabine—kidney cancer	5.23e-05	0.00027	CcSEcCtD
Zoledronate—Pruritus—Gemcitabine—kidney cancer	5.23e-05	0.00027	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—kidney cancer	5.2e-05	0.000268	CcSEcCtD
Zoledronate—CA14—Metabolism—SLC5A5—kidney cancer	5.19e-05	0.00107	CbGpPWpGaD
Zoledronate—Dry mouth—Capecitabine—kidney cancer	5.18e-05	0.000267	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—kidney cancer	5.18e-05	0.000267	CcSEcCtD
Zoledronate—Dizziness—Vincristine—kidney cancer	5.15e-05	0.000266	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—kidney cancer	5.13e-05	0.000265	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—kidney cancer	5.13e-05	0.000265	CcSEcCtD
Zoledronate—Confusional state—Capecitabine—kidney cancer	5.12e-05	0.000264	CcSEcCtD
Zoledronate—Feeling abnormal—Paclitaxel—kidney cancer	5.1e-05	0.000263	CcSEcCtD
Zoledronate—CA12—Metabolism—ACHE—kidney cancer	5.08e-05	0.00105	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTT1—kidney cancer	5.08e-05	0.00105	CbGpPWpGaD
Zoledronate—Oedema—Capecitabine—kidney cancer	5.07e-05	0.000262	CcSEcCtD
Zoledronate—Gastrointestinal pain—Paclitaxel—kidney cancer	5.06e-05	0.000261	CcSEcCtD
Zoledronate—Diarrhoea—Gemcitabine—kidney cancer	5.05e-05	0.000261	CcSEcCtD
Zoledronate—ABCC1—Disease—AMER1—kidney cancer	5.04e-05	0.00104	CbGpPWpGaD
Zoledronate—Renal failure—Doxorubicin—kidney cancer	5.04e-05	0.00026	CcSEcCtD
Zoledronate—Infection—Capecitabine—kidney cancer	5.04e-05	0.00026	CcSEcCtD
Zoledronate—CA14—Metabolism—SLC2A1—kidney cancer	5.01e-05	0.00103	CbGpPWpGaD
Zoledronate—Stomatitis—Doxorubicin—kidney cancer	5e-05	0.000258	CcSEcCtD
Zoledronate—Shock—Capecitabine—kidney cancer	4.99e-05	0.000258	CcSEcCtD
Zoledronate—FDPS—Metabolism—SCARB1—kidney cancer	4.99e-05	0.00103	CbGpPWpGaD
Zoledronate—Conjunctivitis—Doxorubicin—kidney cancer	4.99e-05	0.000257	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—kidney cancer	4.99e-05	0.000257	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.98e-05	0.00103	CbGpPWpGaD
Zoledronate—Nervous system disorder—Capecitabine—kidney cancer	4.98e-05	0.000257	CcSEcCtD
Zoledronate—Thrombocytopenia—Capecitabine—kidney cancer	4.97e-05	0.000256	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PDHB—kidney cancer	4.97e-05	0.00102	CbGpPWpGaD
Zoledronate—Tachycardia—Capecitabine—kidney cancer	4.95e-05	0.000255	CcSEcCtD
Zoledronate—Vomiting—Vincristine—kidney cancer	4.95e-05	0.000255	CcSEcCtD
Zoledronate—FDPS—Metabolism—PTGS1—kidney cancer	4.94e-05	0.00102	CbGpPWpGaD
Zoledronate—Skin disorder—Capecitabine—kidney cancer	4.93e-05	0.000254	CcSEcCtD
Zoledronate—Urticaria—Paclitaxel—kidney cancer	4.91e-05	0.000253	CcSEcCtD
Zoledronate—Rash—Vincristine—kidney cancer	4.91e-05	0.000253	CcSEcCtD
Zoledronate—Hyperhidrosis—Capecitabine—kidney cancer	4.91e-05	0.000253	CcSEcCtD
Zoledronate—Dermatitis—Vincristine—kidney cancer	4.9e-05	0.000253	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—kidney cancer	4.89e-05	0.000252	CcSEcCtD
Zoledronate—Body temperature increased—Paclitaxel—kidney cancer	4.89e-05	0.000252	CcSEcCtD
Zoledronate—Abdominal pain—Paclitaxel—kidney cancer	4.89e-05	0.000252	CcSEcCtD
Zoledronate—Headache—Vincristine—kidney cancer	4.88e-05	0.000252	CcSEcCtD
Zoledronate—FDPS—Metabolism—PSMD7—kidney cancer	4.84e-05	0.000999	CbGpPWpGaD
Zoledronate—Anorexia—Capecitabine—kidney cancer	4.84e-05	0.00025	CcSEcCtD
Zoledronate—CA12—Metabolism—SCARB1—kidney cancer	4.81e-05	0.000992	CbGpPWpGaD
Zoledronate—Agranulocytosis—Doxorubicin—kidney cancer	4.79e-05	0.000247	CcSEcCtD
Zoledronate—CA12—Metabolism—PTGS1—kidney cancer	4.76e-05	0.000982	CbGpPWpGaD
Zoledronate—Hypotension—Capecitabine—kidney cancer	4.74e-05	0.000245	CcSEcCtD
Zoledronate—Vomiting—Gemcitabine—kidney cancer	4.7e-05	0.000242	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—kidney cancer	4.69e-05	0.000242	CcSEcCtD
Zoledronate—CA12—Metabolism—PSMD7—kidney cancer	4.67e-05	0.000963	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CCBL1—kidney cancer	4.67e-05	0.000963	CbGpPWpGaD
Zoledronate—Rash—Gemcitabine—kidney cancer	4.66e-05	0.00024	CcSEcCtD
Zoledronate—Dermatitis—Gemcitabine—kidney cancer	4.65e-05	0.00024	CcSEcCtD
Zoledronate—Headache—Gemcitabine—kidney cancer	4.63e-05	0.000239	CcSEcCtD
Zoledronate—Nausea—Vincristine—kidney cancer	4.62e-05	0.000239	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.62e-05	0.000238	CcSEcCtD
Zoledronate—FDPS—Metabolism—BCHE—kidney cancer	4.59e-05	0.000947	CbGpPWpGaD
Zoledronate—Insomnia—Capecitabine—kidney cancer	4.59e-05	0.000237	CcSEcCtD
Zoledronate—CA2—Metabolism—CRABP1—kidney cancer	4.58e-05	0.000945	CbGpPWpGaD
Zoledronate—Hypoaesthesia—Doxorubicin—kidney cancer	4.58e-05	0.000236	CcSEcCtD
Zoledronate—Paraesthesia—Capecitabine—kidney cancer	4.56e-05	0.000235	CcSEcCtD
Zoledronate—Hypersensitivity—Paclitaxel—kidney cancer	4.56e-05	0.000235	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—kidney cancer	4.55e-05	0.000235	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—kidney cancer	4.54e-05	0.000234	CcSEcCtD
Zoledronate—FDPS—Metabolism—SLC5A5—kidney cancer	4.53e-05	0.000935	CbGpPWpGaD
Zoledronate—Connective tissue disorder—Doxorubicin—kidney cancer	4.52e-05	0.000233	CcSEcCtD
Zoledronate—Dyspnoea—Capecitabine—kidney cancer	4.52e-05	0.000233	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—kidney cancer	4.51e-05	0.000233	CcSEcCtD
Zoledronate—Dyspepsia—Capecitabine—kidney cancer	4.47e-05	0.00023	CcSEcCtD
Zoledronate—Asthenia—Paclitaxel—kidney cancer	4.44e-05	0.000229	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTGS2—kidney cancer	4.43e-05	0.000914	CbGpPWpGaD
Zoledronate—CA12—Metabolism—BCHE—kidney cancer	4.43e-05	0.000913	CbGpPWpGaD
Zoledronate—Decreased appetite—Capecitabine—kidney cancer	4.41e-05	0.000228	CcSEcCtD
Zoledronate—Nausea—Gemcitabine—kidney cancer	4.39e-05	0.000226	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Capecitabine—kidney cancer	4.38e-05	0.000226	CcSEcCtD
Zoledronate—FDPS—Metabolism—SLC2A1—kidney cancer	4.38e-05	0.000903	CbGpPWpGaD
Zoledronate—Fatigue—Capecitabine—kidney cancer	4.38e-05	0.000226	CcSEcCtD
Zoledronate—Pruritus—Paclitaxel—kidney cancer	4.37e-05	0.000226	CcSEcCtD
Zoledronate—CA12—Metabolism—SLC5A5—kidney cancer	4.37e-05	0.000902	CbGpPWpGaD
Zoledronate—Pain—Capecitabine—kidney cancer	4.34e-05	0.000224	CcSEcCtD
Zoledronate—Constipation—Capecitabine—kidney cancer	4.34e-05	0.000224	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—kidney cancer	4.3e-05	0.000222	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—kidney cancer	4.27e-05	0.00022	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—kidney cancer	4.27e-05	0.00022	CcSEcCtD
Zoledronate—CA2—Metabolism—ITPR2—kidney cancer	4.26e-05	0.000878	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.25e-05	0.000876	CbGpPWpGaD
Zoledronate—Diarrhoea—Paclitaxel—kidney cancer	4.23e-05	0.000218	CcSEcCtD
Zoledronate—ABCC1—Disease—GPC3—kidney cancer	4.23e-05	0.000871	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC2A1—kidney cancer	4.22e-05	0.000871	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.22e-05	0.000871	CbGpPWpGaD
Zoledronate—Feeling abnormal—Capecitabine—kidney cancer	4.18e-05	0.000216	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTP1—kidney cancer	4.18e-05	0.000862	CbGpPWpGaD
Zoledronate—Angiopathy—Doxorubicin—kidney cancer	4.18e-05	0.000215	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—kidney cancer	4.16e-05	0.000215	CcSEcCtD
Zoledronate—Gastrointestinal pain—Capecitabine—kidney cancer	4.15e-05	0.000214	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—kidney cancer	4.15e-05	0.000214	CcSEcCtD
Zoledronate—Chills—Doxorubicin—kidney cancer	4.13e-05	0.000213	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—kidney cancer	4.11e-05	0.000212	CcSEcCtD
Zoledronate—Dizziness—Paclitaxel—kidney cancer	4.09e-05	0.000211	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—kidney cancer	4.07e-05	0.00021	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GLIPR1—kidney cancer	4.05e-05	0.000835	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPAT—kidney cancer	4.05e-05	0.000835	CbGpPWpGaD
Zoledronate—Mental disorder—Doxorubicin—kidney cancer	4.03e-05	0.000208	CcSEcCtD
Zoledronate—Urticaria—Capecitabine—kidney cancer	4.03e-05	0.000208	CcSEcCtD
Zoledronate—Abdominal pain—Capecitabine—kidney cancer	4.01e-05	0.000207	CcSEcCtD
Zoledronate—Body temperature increased—Capecitabine—kidney cancer	4.01e-05	0.000207	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—kidney cancer	4.01e-05	0.000207	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—kidney cancer	4.01e-05	0.000207	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4e-05	0.000824	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.96e-05	0.000816	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCB1—kidney cancer	3.96e-05	0.000816	CbGpPWpGaD
Zoledronate—Vomiting—Paclitaxel—kidney cancer	3.93e-05	0.000203	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—kidney cancer	3.92e-05	0.000202	CcSEcCtD
Zoledronate—ABCC1—Disease—ST3GAL2—kidney cancer	3.91e-05	0.000806	CbGpPWpGaD
Zoledronate—Rash—Paclitaxel—kidney cancer	3.9e-05	0.000201	CcSEcCtD
Zoledronate—Dermatitis—Paclitaxel—kidney cancer	3.9e-05	0.000201	CcSEcCtD
Zoledronate—CA2—Metabolism—ACHE—kidney cancer	3.88e-05	0.000801	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTT1—kidney cancer	3.88e-05	0.000801	CbGpPWpGaD
Zoledronate—Back pain—Doxorubicin—kidney cancer	3.88e-05	0.0002	CcSEcCtD
Zoledronate—Headache—Paclitaxel—kidney cancer	3.87e-05	0.0002	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTEN—kidney cancer	3.87e-05	0.000797	CbGpPWpGaD
Zoledronate—Muscle spasms—Doxorubicin—kidney cancer	3.85e-05	0.000199	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTM1—kidney cancer	3.84e-05	0.000792	CbGpPWpGaD
Zoledronate—Vision blurred—Doxorubicin—kidney cancer	3.78e-05	0.000195	CcSEcCtD
Zoledronate—ABCC1—Metabolism—FH—kidney cancer	3.76e-05	0.000776	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APRT—kidney cancer	3.76e-05	0.000776	CbGpPWpGaD
Zoledronate—Hypersensitivity—Capecitabine—kidney cancer	3.74e-05	0.000193	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—kidney cancer	3.72e-05	0.000192	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.71e-05	0.000764	CbGpPWpGaD
Zoledronate—Anaemia—Doxorubicin—kidney cancer	3.7e-05	0.000191	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—kidney cancer	3.68e-05	0.00019	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.68e-05	0.000759	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SCARB1—kidney cancer	3.68e-05	0.000758	CbGpPWpGaD
Zoledronate—Nausea—Paclitaxel—kidney cancer	3.67e-05	0.000189	CcSEcCtD
Zoledronate—ABCC1—Disease—PGK1—kidney cancer	3.66e-05	0.000755	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC5A3—kidney cancer	3.66e-05	0.000755	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTP1—kidney cancer	3.65e-05	0.000753	CbGpPWpGaD
Zoledronate—Asthenia—Capecitabine—kidney cancer	3.64e-05	0.000188	CcSEcCtD
Zoledronate—CA14—Metabolism—CYP1A1—kidney cancer	3.64e-05	0.000751	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS1—kidney cancer	3.64e-05	0.000751	CbGpPWpGaD
Zoledronate—Malaise—Doxorubicin—kidney cancer	3.61e-05	0.000186	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—kidney cancer	3.6e-05	0.000186	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—kidney cancer	3.59e-05	0.000185	CcSEcCtD
Zoledronate—ABCC1—Disease—LDHB—kidney cancer	3.59e-05	0.000741	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SFRP2—kidney cancer	3.59e-05	0.000741	CbGpPWpGaD
Zoledronate—Pruritus—Capecitabine—kidney cancer	3.59e-05	0.000185	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—kidney cancer	3.59e-05	0.000185	CcSEcCtD
Zoledronate—CA2—Metabolism—PSMD7—kidney cancer	3.57e-05	0.000736	CbGpPWpGaD
Zoledronate—Palpitations—Doxorubicin—kidney cancer	3.54e-05	0.000183	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GPC3—kidney cancer	3.54e-05	0.00073	CbGpPWpGaD
Zoledronate—Loss of consciousness—Doxorubicin—kidney cancer	3.52e-05	0.000182	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTP1—kidney cancer	3.52e-05	0.000726	CbGpPWpGaD
Zoledronate—Cough—Doxorubicin—kidney cancer	3.5e-05	0.00018	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—kidney cancer	3.47e-05	0.000179	CcSEcCtD
Zoledronate—Diarrhoea—Capecitabine—kidney cancer	3.47e-05	0.000179	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—kidney cancer	3.46e-05	0.000178	CcSEcCtD
Zoledronate—FDPS—Metabolism—ABCB1—kidney cancer	3.46e-05	0.000713	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.46e-05	0.000712	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA2—kidney cancer	3.44e-05	0.00071	CbGpPWpGaD
Zoledronate—Myalgia—Doxorubicin—kidney cancer	3.41e-05	0.000176	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—kidney cancer	3.41e-05	0.000176	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—kidney cancer	3.41e-05	0.000176	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—kidney cancer	3.4e-05	0.000175	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.39e-05	0.000175	CcSEcCtD
Zoledronate—CA2—Metabolism—BCHE—kidney cancer	3.38e-05	0.000698	CbGpPWpGaD
Zoledronate—Discomfort—Doxorubicin—kidney cancer	3.37e-05	0.000174	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTM1—kidney cancer	3.36e-05	0.000692	CbGpPWpGaD
Zoledronate—Dizziness—Capecitabine—kidney cancer	3.36e-05	0.000173	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ALAD—kidney cancer	3.35e-05	0.000692	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCEB1—kidney cancer	3.35e-05	0.000691	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCEB2—kidney cancer	3.35e-05	0.000691	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC5A5—kidney cancer	3.34e-05	0.000689	CbGpPWpGaD
Zoledronate—Dry mouth—Doxorubicin—kidney cancer	3.34e-05	0.000172	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.34e-05	0.000688	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—kidney cancer	3.33e-05	0.000687	CbGpPWpGaD
Zoledronate—Confusional state—Doxorubicin—kidney cancer	3.3e-05	0.00017	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ST3GAL2—kidney cancer	3.27e-05	0.000675	CbGpPWpGaD
Zoledronate—Oedema—Doxorubicin—kidney cancer	3.27e-05	0.000169	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—kidney cancer	3.27e-05	0.000169	CcSEcCtD
Zoledronate—Infection—Doxorubicin—kidney cancer	3.25e-05	0.000168	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTM1—kidney cancer	3.24e-05	0.000667	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC2A1—kidney cancer	3.23e-05	0.000666	CbGpPWpGaD
Zoledronate—Vomiting—Capecitabine—kidney cancer	3.23e-05	0.000166	CcSEcCtD
Zoledronate—Shock—Doxorubicin—kidney cancer	3.22e-05	0.000166	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—kidney cancer	3.21e-05	0.000165	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—kidney cancer	3.2e-05	0.000165	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ALDH1A1—kidney cancer	3.2e-05	0.00066	CbGpPWpGaD
Zoledronate—Rash—Capecitabine—kidney cancer	3.2e-05	0.000165	CcSEcCtD
Zoledronate—Dermatitis—Capecitabine—kidney cancer	3.2e-05	0.000165	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—kidney cancer	3.19e-05	0.000165	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP1A1—kidney cancer	3.18e-05	0.000656	CbGpPWpGaD
Zoledronate—Headache—Capecitabine—kidney cancer	3.18e-05	0.000164	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—kidney cancer	3.18e-05	0.000164	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—kidney cancer	3.16e-05	0.000163	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—kidney cancer	3.12e-05	0.000161	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PGK1—kidney cancer	3.07e-05	0.000633	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A3—kidney cancer	3.07e-05	0.000633	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—kidney cancer	3.07e-05	0.000633	CbGpPWpGaD
Zoledronate—Hypotension—Doxorubicin—kidney cancer	3.06e-05	0.000158	CcSEcCtD
Zoledronate—Nausea—Capecitabine—kidney cancer	3.01e-05	0.000155	CcSEcCtD
Zoledronate—ABCC1—Metabolism—LDHB—kidney cancer	3.01e-05	0.00062	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.98e-05	0.000154	CcSEcCtD
Zoledronate—Insomnia—Doxorubicin—kidney cancer	2.96e-05	0.000153	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—kidney cancer	2.94e-05	0.000152	CcSEcCtD
Zoledronate—Dyspnoea—Doxorubicin—kidney cancer	2.92e-05	0.00015	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—kidney cancer	2.91e-05	0.00015	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—kidney cancer	2.88e-05	0.000149	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—kidney cancer	2.84e-05	0.000147	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.82e-05	0.000146	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—kidney cancer	2.82e-05	0.000145	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—kidney cancer	2.8e-05	0.000144	CcSEcCtD
Zoledronate—Pain—Doxorubicin—kidney cancer	2.8e-05	0.000144	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PIK3CA—kidney cancer	2.73e-05	0.000562	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL14—kidney cancer	2.72e-05	0.000561	CbGpPWpGaD
Zoledronate—CA14—Metabolism—POMC—kidney cancer	2.71e-05	0.00056	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—kidney cancer	2.7e-05	0.000139	CcSEcCtD
Zoledronate—CA2—Metabolism—GSTP1—kidney cancer	2.69e-05	0.000555	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Doxorubicin—kidney cancer	2.67e-05	0.000138	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.63e-05	0.000543	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.61e-05	0.000539	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA9—kidney cancer	2.61e-05	0.000538	CbGpPWpGaD
Zoledronate—Urticaria—Doxorubicin—kidney cancer	2.6e-05	0.000134	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—kidney cancer	2.59e-05	0.000133	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—kidney cancer	2.59e-05	0.000133	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.55e-05	0.000526	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—kidney cancer	2.55e-05	0.000526	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—kidney cancer	2.47e-05	0.00051	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ITPR2—kidney cancer	2.46e-05	0.000508	CbGpPWpGaD
Zoledronate—Hypersensitivity—Doxorubicin—kidney cancer	2.41e-05	0.000124	CcSEcCtD
Zoledronate—FDPS—Metabolism—POMC—kidney cancer	2.37e-05	0.000489	CbGpPWpGaD
Zoledronate—Asthenia—Doxorubicin—kidney cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP1A1—kidney cancer	2.35e-05	0.000484	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—kidney cancer	2.31e-05	0.000119	CcSEcCtD
Zoledronate—CA12—Metabolism—POMC—kidney cancer	2.29e-05	0.000472	CbGpPWpGaD
Zoledronate—Diarrhoea—Doxorubicin—kidney cancer	2.24e-05	0.000115	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CRABP1—kidney cancer	2.22e-05	0.000457	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—kidney cancer	2.16e-05	0.000446	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—kidney cancer	2.16e-05	0.000112	CcSEcCtD
Zoledronate—Vomiting—Doxorubicin—kidney cancer	2.08e-05	0.000107	CcSEcCtD
Zoledronate—ABCC1—Disease—PSMD7—kidney cancer	2.06e-05	0.000426	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—kidney cancer	2.06e-05	0.000106	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ITPR2—kidney cancer	2.06e-05	0.000425	CbGpPWpGaD
Zoledronate—Dermatitis—Doxorubicin—kidney cancer	2.06e-05	0.000106	CcSEcCtD
Zoledronate—Headache—Doxorubicin—kidney cancer	2.05e-05	0.000106	CcSEcCtD
Zoledronate—Nausea—Doxorubicin—kidney cancer	1.94e-05	0.0001	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.9e-05	0.000392	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—kidney cancer	1.89e-05	0.00039	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTEN—kidney cancer	1.89e-05	0.000389	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACHE—kidney cancer	1.88e-05	0.000388	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—kidney cancer	1.88e-05	0.000388	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A1—kidney cancer	1.87e-05	0.000385	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JUNB—kidney cancer	1.85e-05	0.000382	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—kidney cancer	1.82e-05	0.000376	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SCARB1—kidney cancer	1.78e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS1—kidney cancer	1.76e-05	0.000363	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—kidney cancer	1.75e-05	0.000361	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMD7—kidney cancer	1.73e-05	0.000356	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—kidney cancer	1.65e-05	0.00034	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCHE—kidney cancer	1.64e-05	0.000338	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A5—kidney cancer	1.62e-05	0.000334	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—kidney cancer	1.59e-05	0.000328	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A1—kidney cancer	1.56e-05	0.000322	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.52e-05	0.000313	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN2B—kidney cancer	1.51e-05	0.000311	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	0.000307	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—kidney cancer	1.4e-05	0.000288	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—kidney cancer	1.33e-05	0.000275	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.32e-05	0.000273	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—kidney cancer	1.3e-05	0.000269	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—kidney cancer	1.23e-05	0.000254	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—kidney cancer	1.22e-05	0.000251	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—kidney cancer	1.21e-05	0.000249	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TSC2—kidney cancer	1.2e-05	0.000248	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—kidney cancer	1.2e-05	0.000247	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—kidney cancer	1.16e-05	0.00024	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000234	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—kidney cancer	1.12e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—kidney cancer	1.06e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KIT—kidney cancer	1.06e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—kidney cancer	9.98e-06	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.33e-06	0.000192	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—kidney cancer	8.58e-06	0.000177	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—kidney cancer	8.47e-06	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAF1—kidney cancer	8.34e-06	0.000172	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—kidney cancer	8.25e-06	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—kidney cancer	8.14e-06	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD4—kidney cancer	8.12e-06	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—kidney cancer	8.06e-06	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—kidney cancer	7.64e-06	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—kidney cancer	7.22e-06	0.000149	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—kidney cancer	7.03e-06	0.000145	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—kidney cancer	6.75e-06	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—kidney cancer	6.01e-06	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—kidney cancer	5.89e-06	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—kidney cancer	5.84e-06	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK1—kidney cancer	5.72e-06	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—kidney cancer	5.4e-06	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—kidney cancer	4.96e-06	0.000102	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—kidney cancer	4.15e-06	8.57e-05	CbGpPWpGaD
